EP1698058A4 - Überwachungsverfahren und -vorrichtung - Google Patents

Überwachungsverfahren und -vorrichtung

Info

Publication number
EP1698058A4
EP1698058A4 EP04814348A EP04814348A EP1698058A4 EP 1698058 A4 EP1698058 A4 EP 1698058A4 EP 04814348 A EP04814348 A EP 04814348A EP 04814348 A EP04814348 A EP 04814348A EP 1698058 A4 EP1698058 A4 EP 1698058A4
Authority
EP
European Patent Office
Prior art keywords
monitoring method
monitoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP04814348A
Other languages
English (en)
French (fr)
Other versions
EP1698058A2 (de
Inventor
Paul Sheard
Marika Reay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere Switzerland GmbH
Original Assignee
Inverness Medical Switzerland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0329288.5A external-priority patent/GB0329288D0/en
Application filed by Inverness Medical Switzerland GmbH filed Critical Inverness Medical Switzerland GmbH
Priority to EP12154998.4A priority Critical patent/EP2452619B1/de
Publication of EP1698058A2 publication Critical patent/EP1698058A2/de
Publication of EP1698058A4 publication Critical patent/EP1698058A4/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
EP04814348A 2003-12-18 2004-12-17 Überwachungsverfahren und -vorrichtung Ceased EP1698058A4 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12154998.4A EP2452619B1 (de) 2003-12-18 2004-12-17 Überwachungsverfahren und -vorrichtung

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0329288.5A GB0329288D0 (en) 2003-12-18 2003-12-18 Monitoring method and apparatus
US62096804P 2004-10-22 2004-10-22
PCT/US2004/042153 WO2005060652A2 (en) 2003-12-18 2004-12-17 Monitoring method and apparatus

Publications (2)

Publication Number Publication Date
EP1698058A2 EP1698058A2 (de) 2006-09-06
EP1698058A4 true EP1698058A4 (de) 2009-09-23

Family

ID=34712700

Family Applications (2)

Application Number Title Priority Date Filing Date
EP04814348A Ceased EP1698058A4 (de) 2003-12-18 2004-12-17 Überwachungsverfahren und -vorrichtung
EP12154998.4A Active EP2452619B1 (de) 2003-12-18 2004-12-17 Überwachungsverfahren und -vorrichtung

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP12154998.4A Active EP2452619B1 (de) 2003-12-18 2004-12-17 Überwachungsverfahren und -vorrichtung

Country Status (6)

Country Link
EP (2) EP1698058A4 (de)
JP (1) JP2007534363A (de)
AU (1) AU2004305066B2 (de)
CA (1) CA2550090C (de)
NZ (1) NZ547986A (de)
WO (1) WO2005060652A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007007177A2 (en) 2005-07-14 2007-01-18 Inverness Medical Switzerland Gmbh Mitochondrial markers of ischemia
WO2007013041A2 (en) * 2005-07-29 2007-02-01 Koninklijke Philips Electronics, N.V. Monitoring of cardiac natriuretic peptides during diagnosis, managment, and treatment of cardiac diseases
WO2008030122A1 (en) * 2006-09-07 2008-03-13 University Of Otago Biomarkers
US8385999B1 (en) 2008-02-08 2013-02-26 Pacesetter, Inc. Processing venous oxygen saturation and hematocrit information in an implantable sensor
EP2294424A1 (de) 2008-05-21 2011-03-16 F. Hoffmann-La Roche AG L-fabp, natriuretische peptide und herztroponin bei individuen, die eine herztherapie benötigen
WO2010033699A1 (en) 2008-09-19 2010-03-25 Cardiac Pacemakers, Inc. Indication-based worsening hf alert
BR112013032238A2 (pt) * 2011-06-17 2016-12-20 Ct Hospitalier Universitaire De Nancy Chu método para a determinação de uma variação do volume plasmático e dispositivos para implementar o método
EP2938248A4 (de) * 2012-12-31 2016-09-07 M I Medical Incentive Ltd Diagnostisches überwachungssystem und verfahren für kardiovaskuläres screening
EP2999396B1 (de) 2013-05-20 2023-11-08 Cardiac Pacemakers, Inc. Vorrichtung für herzinsuffizienzrisikostratifizierung
EP2999395A1 (de) 2013-05-20 2016-03-30 Cardiac Pacemakers, Inc. Verfahren und vorrichtung zur detektion von herzversagen
EP2899544B1 (de) * 2014-01-28 2018-12-26 Roche Diagnostics GmbH Biomarker zur Risikobewertung und Behandlungsüberwachung bei Patienten mit Herzinsuffizienz, die auf Basis des natriuretischen Peptids des Typs B behandelt werden
JP6169997B2 (ja) * 2014-02-06 2017-07-26 吉田　昌義 心不全又は腎不全発症警告装置
JP2018531672A (ja) * 2015-09-23 2018-11-01 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 患者モニタ上にコンテキストが追加されたパルスオキシメータ
CN110868911B (zh) 2017-04-29 2022-10-11 心脏起搏器股份公司 心力衰竭事件率评定
WO2020080482A1 (ja) * 2018-10-17 2020-04-23 株式会社 資生堂 血液中のシスタチンｃ量に基づく腎機能検査結果の妥当性を検定する方法
TW202022379A (zh) * 2018-10-17 2020-06-16 日商資生堂股份有限公司 檢定根據血液中之肌酸酐含量之腎功能檢查結果之妥當性之方法
EP4035171A1 (de) * 2019-09-27 2022-08-03 CardioRenal Gesamtschleifensystem
WO2023282600A1 (ko) * 2021-07-09 2023-01-12 서울대학교병원 수술 중 또는 수술 후 예후 판단 장치 및 방법
KR102510680B1 (ko) * 2021-07-09 2023-03-16 서울대학교병원 수술 중 또는 수술 후 예후 판단 장치 및 방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661122A (en) * 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
US6410524B1 (en) * 1998-11-06 2002-06-25 G. D. Searle & Co. Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
WO2002080847A2 (en) * 2001-04-06 2002-10-17 Immunex Corporation Use of tumor necrosis factor inhibitors to treat cardiovascular disease
US20020170823A1 (en) * 2001-05-18 2002-11-21 Housefield T. Scott Body fluid test apparatus with detachably mounted portable tester
US20030073931A1 (en) * 2001-10-16 2003-04-17 Dirk Boecker Universal diagnostic platform

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
EP0290683A3 (de) * 1987-05-01 1988-12-14 Diva Medical Systems B.V. System und Vorrichtung zur medizinischen Behandlung der Zuckerkrankheit
EP0653639B1 (de) 1993-11-12 2000-03-22 Unilever Plc Analysevorrichtung und deren Anwendung
EP0653625B1 (de) 1993-11-12 2002-09-11 Inverness Medical Switzerland GmbH Vorrichtung zum Ablesen von Teststreifen
GB9419267D0 (en) 1994-09-23 1994-11-09 Unilever Plc Assay devices
CA2324096A1 (en) * 1998-03-10 1999-09-16 Strategic Diagnostics, Inc. Integrated assay device and methods of production and use
CA2413205A1 (en) * 2000-06-26 2002-01-03 Boston Medical Technologies, Inc. Glucose metering system
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
JP2005516015A (ja) * 2001-12-13 2005-06-02 ファルマシア・コーポレイション エポキシステロイドアルドステロン拮抗薬を用いる対象におけるアルドステロン媒介病原性効果を治療または予防する方法
DK1638443T3 (da) * 2003-06-20 2011-02-07 Mayo Foundation Isoformer af hjerne-natriuretisk peptid
US8002553B2 (en) * 2003-08-18 2011-08-23 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661122A (en) * 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
US6410524B1 (en) * 1998-11-06 2002-06-25 G. D. Searle & Co. Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
WO2002080847A2 (en) * 2001-04-06 2002-10-17 Immunex Corporation Use of tumor necrosis factor inhibitors to treat cardiovascular disease
US20020170823A1 (en) * 2001-05-18 2002-11-21 Housefield T. Scott Body fluid test apparatus with detachably mounted portable tester
US20030073931A1 (en) * 2001-10-16 2003-04-17 Dirk Boecker Universal diagnostic platform

Also Published As

Publication number Publication date
NZ547986A (en) 2009-08-28
CA2550090A1 (en) 2005-07-07
WO2005060652A2 (en) 2005-07-07
CA2550090C (en) 2013-04-16
WO2005060652A3 (en) 2006-03-23
AU2004305066A1 (en) 2005-07-07
EP2452619A1 (de) 2012-05-16
AU2004305066B2 (en) 2010-04-01
EP1698058A2 (de) 2006-09-06
JP2007534363A (ja) 2007-11-29
EP2452619B1 (de) 2013-10-02

Similar Documents

Publication Publication Date Title
GB2398312B (en) Apparatus and method
GB2401005B (en) Methods and apparatus for alternative mode monitoring
EP1698058A4 (de) Überwachungsverfahren und -vorrichtung
GB0305899D0 (en) Method and apparatus for monitoring element alignment
GB2407857B (en) Apparatus and method
GB2416105B (en) Fence condition monitoring apparatus and method
GB0327981D0 (en) De-blistering apparatus and method
GB0421148D0 (en) Monitoring apparatus and method therefor
GB0315475D0 (en) Apparatus and method
GB0305023D0 (en) Apparatus and method
GB2402865B (en) De-Infestation method and apparatus
GB0224310D0 (en) Apparatus and method for cross section monitoring
GB2388456B (en) Monitoring apparatus and method
GB0410751D0 (en) Apparatus and method
GB0328090D0 (en) Apparatus and method
GB0303973D0 (en) Method and apparatus
GB2404238B (en) Apparatus and method
GB0407679D0 (en) Method and apparatus
GB0313439D0 (en) Apparatus and method
GB2409367B (en) Method and apparatus
AU2003906421A0 (en) Object monitoring method and apparatus
GB0314990D0 (en) Apparatus and method
GB0403325D0 (en) Apparatus and method
GB0326900D0 (en) Apparatus and method
GB0317120D0 (en) Method and apparatus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060707

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INVERNESS MEDICAL SWITZERLAND GMBH

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/02 20060101AFI20061010BHEP

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1096274

Country of ref document: HK

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INVERNESS MEDICAL SWITZERLAND GMBH

RIN1 Information on inventor provided before grant (corrected)

Inventor name: REAY, MARIKA

Inventor name: SHEARD, PAUL

A4 Supplementary search report drawn up and despatched

Effective date: 20090820

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/00 20060101AFI20090814BHEP

17Q First examination report despatched

Effective date: 20100210

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ALERIS SWITZERLAND GMBH

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ALERE SWITZERLAND GMBH

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20130331

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1096274

Country of ref document: HK